{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:29:23Z","timestamp":1790630963734,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T00:00:00Z","timestamp":1148342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1471-244x-6-22","type":"journal-article","created":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T14:27:00Z","timestamp":1148394420000},"source":"Crossref","is-referenced-by-count":44,"title":["Topiramate in the treatment of compulsive sexual behavior: case report"],"prefix":"10.1186","volume":"6","author":[{"given":"Yasser","family":"Khazaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Fabio","family":"Zullino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,23]]},"reference":[{"key":"151_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/sj.npp.1300350","volume":"29","author":"ME Balfour","year":"2004","unstructured":"Balfour ME, Yu L, Coolen LM: Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats. Neuropsychopharmacology. 2004, 29: 718-730. 10.1038\/sj.npp.1300350.","journal-title":"Neuropsychopharmacology"},{"key":"151_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0163-7258(00)00078-4","volume":"88","author":"A Jackson","year":"2000","unstructured":"Jackson A, Mead AN, Stephens DN: Behavioural effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse. Pharmacol Ther. 2000, 88: 59-76. 10.1016\/S0163-7258(00)00078-4.","journal-title":"Pharmacol Ther"},{"key":"151_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0306-4522(99)00214-6","volume":"93","author":"JL Cornish","year":"1999","unstructured":"Cornish JL, Duffy P, Kalivas PW: A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience. 1999, 93: 1359-1367. 10.1016\/S0306-4522(99)00214-6.","journal-title":"Neuroscience"},{"key":"151_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1058043","volume":"292","author":"SR Vorel","year":"2001","unstructured":"Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL: Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science. 2001, 292: 1175-1178. 10.1126\/science.1058043.","journal-title":"Science"},{"key":"151_CR5","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1111\/j.1528-1157.2000.tb02164.x","volume":"41 Suppl 1","author":"JWIII Gibbs","year":"2000","unstructured":"Gibbs JWIII, Sombati S, DeLorenzo RJ, Coulter DA: Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia. 2000, 41 Suppl 1: S10-S16. 10.1111\/j.1528-1157.2000.tb02164.x.","journal-title":"Epilepsia"},{"key":"151_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4088\/JCP.v64n0215f","volume":"64","author":"DF Zullino","year":"2003","unstructured":"Zullino DF, Krenz S, Besson J: AMPA blockade may be the mechanism underlying the efficacy of topiramate in PTSD. J Clin Psychiatry. 2003, 64: 219-220.","journal-title":"J Clin Psychiatry"},{"key":"151_CR7","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","volume":"361","author":"BA Johnson","year":"2003","unstructured":"Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ: Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003, 361: 1677-1685. 10.1016\/S0140-6736(03)13370-3.","journal-title":"Lancet"},{"key":"151_CR8","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.addbeh.2004.06.014","volume":"29","author":"BA Johnson","year":"2004","unstructured":"Johnson BA: Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?. Addict Behav. 2004, 29: 1465-1479. 10.1016\/j.addbeh.2004.06.014.","journal-title":"Addict Behav"},{"key":"151_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1300\/J465v25n04_04","volume":"25","author":"DF Zullino","year":"2005","unstructured":"Zullino DF, Krenz S, Zimmerman G, Miozzari A, Rajeswaran R, Kolly S, Khazaal Y: Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine\/mianserin. Subst Abus. 2005, 25: 27-33. 10.1300\/J465v25n04_04.","journal-title":"Subst Abus"},{"key":"151_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/hup.497","volume":"18","author":"M Cheseaux","year":"2003","unstructured":"Cheseaux M, Monnat M, Zullino DF: Topiramate in benzodiazepine withdrawal. Hum Psychopharmacol. 2003, 18: 375-377. 10.1002\/hup.497.","journal-title":"Hum Psychopharmacol"},{"key":"151_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1176\/appi.ajp.160.2.255","volume":"160","author":"SL McElroy","year":"2003","unstructured":"McElroy SL, Arnold LM, Shapira NA, Keck PEJ, Rosenthal NR, Karim MR, Kamin M, Hudson JI: Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry. 2003, 160: 255-261. 10.1176\/appi.ajp.160.2.255.","journal-title":"Am J Psychiatry"},{"key":"151_CR12","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4088\/JCP.v64n1109","volume":"64","author":"SP Hoopes","year":"2003","unstructured":"Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, Capece JA, Karvois D: Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry. 2003, 64: 1335-1341.","journal-title":"J Clin Psychiatry"},{"key":"151_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/oby.2003.102","volume":"11","author":"GA Bray","year":"2003","unstructured":"Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH: A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res. 2003, 11: 722-733.","journal-title":"Obes Res"},{"key":"151_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1176\/appi.ajp.158.6.968","volume":"158","author":"FS Abuzzahab","year":"2001","unstructured":"Abuzzahab FS, Brown VL: Control of Tourette's syndrome with topiramate. Am J Psychiatry. 2001, 158: 968-","journal-title":"Am J Psychiatry"},{"key":"151_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-244X-4-24","volume":"4","author":"JL Berlant","year":"2004","unstructured":"Berlant JL: Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. BMC Psychiatry. 2004, 4: 24-10.1186\/1471-244X-4-24.","journal-title":"BMC Psychiatry"},{"key":"151_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1034\/j.1399-5618.2001.030306.x","volume":"3","author":"P Cassano","year":"2001","unstructured":"Cassano P, Lattanzi L, Pini S, Dell'Osso L, Battistini G, Cassano GB: Topiramate for self-mutilation in a patient with borderline personality disorder. Bipolar Disord. 2001, 3: 161-10.1034\/j.1399-5618.2001.030306.x.","journal-title":"Bipolar Disord"},{"key":"151_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/00926239308404908","volume":"19","author":"A Goodman","year":"1993","unstructured":"Goodman A: Diagnosis and treatment of sexual addiction. J Sex Marital Ther. 1993, 19: 225-251.","journal-title":"J Sex Marital Ther"},{"key":"151_CR18","first-page":"282","volume":"61","author":"E Coleman","year":"2000","unstructured":"Coleman E, Gratzer T, Nesvacil L, Raymond NC: Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study. J Clin Psychiatry. 2000, 61: 282-284.","journal-title":"J Clin Psychiatry"},{"key":"151_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/10401239409149003","volume":"6","author":"MP Kafka","year":"1994","unstructured":"Kafka MP: Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry. 1994, 6: 189-195.","journal-title":"Ann Clin Psychiatry"},{"key":"151_CR20","first-page":"351","volume":"53","author":"MP Kafka","year":"1992","unstructured":"Kafka MP, Prentky R: Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry. 1992, 53: 351-358.","journal-title":"J Clin Psychiatry"},{"key":"151_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00004850-200207000-00008","volume":"17","author":"NC Raymond","year":"2002","unstructured":"Raymond NC, Grant JE, Kim SW, Coleman E: Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies. Int Clin Psychopharmacol. 2002, 17: 201-205. 10.1097\/00004850-200207000-00008.","journal-title":"Int Clin Psychopharmacol"},{"key":"151_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00004850-200607000-00007","volume":"21","author":"IS Shiah","year":"2006","unstructured":"Shiah IS, Chao CY, Mao WC, Chuang YJ: Treatment of paraphilic sexual disorder: the use of topiramate in fetishism. Int Clin Psychopharmacol. 2006, 21: 241-243. 10.1097\/00004850-200607000-00007.","journal-title":"Int Clin Psychopharmacol"},{"key":"151_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/01.jcp.0000177849.23534.bf","volume":"25","author":"TW Fong","year":"2005","unstructured":"Fong TW, De La GR, Newton TF: A case report of topiramate in the treatment of nonparaphilic sexual addiction. J Clin Psychopharmacol. 2005, 25: 512-514. 10.1097\/01.jcp.0000177849.23534.bf.","journal-title":"J Clin Psychopharmacol"},{"key":"151_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","volume":"75","author":"KM Kampman","year":"2004","unstructured":"Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP: A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend. 2004, 75: 233-240. 10.1016\/j.drugalcdep.2004.03.008.","journal-title":"Drug Alcohol Depend"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-6-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-6-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-6-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-6-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T01:27:21Z","timestamp":1548206841000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-6-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-6-22","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,23]]},"article-number":"22"}}